Search results with tag "Of biotech"

Valuation and Deal Structuring

M&A Mania –M&As by value up, 168% from 2013, even eclipsed the recent high in 2009. Allergan deal and commercial consolidation dominated. Biotech less than 10% of this volume. Number of Biotech Out-licensing Deals –Still running flat compared to recent years. Value of those Deals –Continued climb in valuations from already healthy levels.

  Valuation, Biotech, Of biotech